SciVision Biotech Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 183.27 million compared to TWD 132.21 million a year ago. Net income was TWD 51.19 million compared to TWD 39.66 million a year ago. Basic earnings per share from continuing operations was TWD 0.77 compared to TWD 0.6 a year ago. Diluted earnings per share from continuing operations was TWD 0.71 compared to TWD 0.6 a year ago.
For the six months, sales was TWD 303.64 million compared to TWD 232.58 million a year ago. Net income was TWD 83.97 million compared to TWD 66.63 million a year ago. Basic earnings per share from continuing operations was TWD 1.26 compared to TWD 1.01 a year ago. Diluted earnings per share from continuing operations was TWD 1.18 compared to TWD 1 a year ago.